Scribd
Upload
10 views1 page

D, S Tramadol

The document discusses the drug tramadol, including its classification as an opioid analgesic, mechanism of action involving multiple receptor sites, common indications for use in relieving moderate to severe pain, potential side effects like sweating and nausea, and nursing responsibilities when administering the drug.

Uploaded by

Kate Cortina
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
10 views1 page

D, S Tramadol

The document discusses the drug tramadol, including its classification as an opioid analgesic, mechanism of action involving multiple receptor sites, common indications for use in relieving moderate to severe pain, potential side effects like sweating and nausea, and nursing responsibilities when administering the drug.

Uploaded by

Kate Cortina
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 1

DRUG CLASSIFICATION MECHANISM OF INDICATION SIDE NURSING

NAME ACTION EFFECTS RESPONSIBILITIES

Generic - Opioid analgesic Tramadol acts as -Relief of moderate to -Sweating 1) Determine


Name: a μ-opioid moderately severe pain. patient’s past or
Tramadol receptor agonist, -Dizziness present history of
serotonin releasing CONTRAINDICATION addiction to or
agent, norepinephr -Nausea dependence on
Brand ine reuptake -Hypersensitivity to the opoids.
Name: inhibitor, NMDA drug -Dry mouth
Ultram receptor antagonist 2) Instruct patient to
5-HT2C receptor -Raised intracranial -Fatigue increase fluid intake
Dosage: antagonist, pressure to prevent dry mouth
50 mg PRN (α7)5 nicotinic -Constipation and constipation.
for severe acetylcholine -Severe renal
pain receptor antagonist impairment 3) For better
TRPV1 receptor analgesic effect, give
Route: agonist, drugs before onset of
Intravenous and M1 and M3 mu intense pain.
scarinic
acetylcholine 4) Reassess level of
receptor pain at least 30
antagonist. minutes after
administration.

5) Monitor CV and
respiratory status.
Withhold dose and
notify prescriber if
respirations decrease
or rate is below 12
breaths/minute.

SUBMITTED BY: BUSTILLO, IAN CHESTER S.

You might also like